HCA Midwest Kansas City, MidAmerica Division, Inc. — Kansas City, Missouri

HCA Midwest Kansas City, MidAmerica Division, Inc. is a clinical research site located in Kansas City, Missouri, United States 37203.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

HCA Midwest Kansas City, MidAmerica Division, Inc. has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Ovarian Neoplasms, Fallopian Tube Neoplasms.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Kansas City, MidAmerica Division, Inc.?

HCA Midwest Kansas City, MidAmerica Division, Inc. has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Kansas City, MidAmerica Division, Inc. conducted?

HCA Midwest Kansas City, MidAmerica Division, Inc. has 2 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Ovarian Neoplasms, Fallopian Tube Neoplasms.

Is HCA Midwest Kansas City, MidAmerica Division, Inc. accredited by Crixeo Health?

HCA Midwest Kansas City, MidAmerica Division, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Kansas City, MidAmerica Division, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.